⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL716147 | 1.00 | HSD17B10 (0.52) | — | |
| SCHEMBL8437357 | 1.00 | HSD17B10 (0.52) | — | |
| SCHEMBL415172 | 1.00 | — | — | |
| SCHEMBL15183 | 1.00 | — | — | |
| Water SCHEMBL9489870 | 0.97 | HSD17B10 (0.50) | — | |
| Hydrochloric Acid SCHEMBL8061170 | 0.97 | — | — | |
| SCHEMBL2013782 | 0.97 | — | — | |
| SCHEMBL21403239 | 0.97 | — | — | |
| SCHEMBL28488201 | 0.97 | — | — | |
| Iodide SCHEMBL30233141 | 0.97 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 473 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-110862303-A | Preparation method of s-metolachlor | 上海科利生物医药有限公司 | 2020-03-06 | — | — | CN | claimed |
| CN-103922960-B | A kind of synthetic method of S-metolachlor | ZHEJIANG ZHONGSHAN CHEMICAL GROUP STOCK CO., LTD. (CN) | 2015-10-21 | — | — | CN | claimed |
| CN-103922960-A | Synthetic method of S-metolachlor | ZHEJIANG ZHONGSHAN CHEMICAL GROUP CO LTD | 2014-07-16 | — | — | CN | claimed |
| WO-2011151434-A1 | NOVEL COMPOUNDS, PHARMACEUTICAL COMPOSITION AND METHODS FOR USE IN TREATING METABOLIC DISORDERS | EUROSCREEN S.A. (BE) | 2011-12-08 | — | — | WO | claimed |
| WO-2001053239-A1 | PREPARATION OF OPTICALLY ACTIVE 1-ALKOXY OR ARYLOXY-2-ALKANOL COMPOUNDS | PPG-SIPSY SCA (FR) | 2001-07-26 | — | — | WO | claimed |
| CN-122055369-A | Bridged tricyclic carbamoyl pyridone compounds and uses thereof | 吉利德科学公司 | 2026-05-15 | — | — | CN | disclosed |
| US-20260116891-A1 | Oxazepin Derivative | TEIJIN PHARMA LTD (JP) | 2026-04-30 | — | — | US | disclosed |
| US-12595265-B2 | Inhibitors of activin receptor-like kinase | BLUEPRINT MEDICINES CORPORATION (US) | 2026-04-07 | — | — | US | disclosed |
| EP-4652164-A1 | INHIBITORS OF CYCLIC GMP-AMP SYNTHASE AND USES THEREOF | Ventus Therapeutics U.S., Inc. (US) | 2025-11-26 | — | — | EP | disclosed |
| EP-4539840-A1 | KINASE MODULATORS AND METHODS OF USE THEREOF | Neuron23, Inc. (US) | 2025-04-23 | — | — | EP | disclosed |
| US-20250122219-A1 | BRIDGED TRICYCLIC CARBAMOYLPYRIDONE COMPOUNDS AND USES THEREOF | GILEAD SCIENCES, INC. | 2025-04-17 | — | — | US | disclosed |
| WO-2025080863-A1 | BRIDGED TRICYCLIC CARBAMOYLPYRIDONE COMPOUNDS AND USES THEREOF | GILEAD SCIENCES, INC. (US) | 2025-04-17 | — | — | WO | disclosed |
| US-6458951-B2 | FOR TREATMENT OF MALE ERECTILE DYSFUNCTION, FEMALE SEXUAL DYSFUNCTION | PFIZER INC | 2002-10-01 | — | — | US | disclosed |
| US-20010039271-A1 | Pyrazolopyrimidinone cGMP PDE5 inhibitors for the treatment of sexual dysfunction | BUNNAGE MARK EDWARD (GB) | 2001-11-08 | — | — | US | disclosed |
| WO-2001053239-A1 | PREPARATION OF OPTICALLY ACTIVE 1-ALKOXY OR ARYLOXY-2-ALKANOL COMPOUNDS | PPG-SIPSY SCA (FR) | 2001-07-26 | — | — | WO | disclosed |
| US-6251904-B1 | Pyrazolopyrimidinone cGMP PDE5 inhibitors for the treatment of sexual dysfunction | PFIZER INC. | 2001-06-26 | — | — | US | disclosed |
| CN-1292379-A | Preparation method of pyrazolzo [4,3-d] pyrimidine-7-ketone-3-pyridyl sulfonyl compound and its intermediate | PFIZER (US) | 2001-04-25 | — | — | CN | disclosed |
| EP-1092720-A2 | Process for the preparation of pyrazolo [4,3-d] pyrimidin-7-ones-3-pyridylsulphonyl compounds and intermediates thereof | Pfizer Limited (GB) | 2001-04-18 | — | — | EP | disclosed |
| EP-1073658-A1 | PYRAZOLOPYRIMIDINONE CGMP PDE5 INHIBITORS FOR THE TREATMENT OF SEXUAL DYSFUNCTION | PFIZER INC. (US) | 2001-02-07 | — | — | EP | disclosed |
| WO-1999054333-A1 | PYRAZOLOPYRIMIDINONE CGMP PDE5 INHIBITORS FOR THE TREATMENT OF SEXUAL DYSFUNCTION | PFIZER INC. (US) | 1999-10-28 | — | — | WO | disclosed |